Pseudomonas aeruginosa in Children With Cystic Fibrosis Diagnosed Through Newborn Screening: Assessment of Clinic Exposures and Microbial Genotypes

被引:12
|
作者
Hayes, Don, Jr. [2 ,3 ]
West, Susan E. [4 ]
Rock, Michael J. [1 ]
Li, Zhanhai [5 ]
Splaingard, Mark L. [6 ,7 ]
Farrell, Philip M. [1 ]
机构
[1] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53726 USA
[2] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY USA
[3] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA
[4] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53726 USA
[5] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA
[6] Ohio State Univ, Childrens Hosp, Coll Med & Publ Hlth, Columbus, OH USA
[7] Ohio State Univ, Dept Pediat, Coll Med & Publ Hlth, Columbus, OH 43210 USA
基金
美国国家卫生研究院;
关键词
Pseudomonas aeruginosa; cystic fibrosis; newborn screening; arbitrarily primed polymerase chain reaction; genotype; segregated clinic; integrated clinic; YOUNG-CHILDREN; RISK-FACTORS; LUNG-DISEASE; INFECTION; STRAINS; EPIDEMIOLOGY; ACQUISITION; COLONIZATION; SPREAD;
D O I
10.1002/ppul.21263
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Chronic pulmonary infection with Pseudomonas aeruginosa (PA) is responsible for significant morbidity and mortality in cystic fibrosis (CF). Because of the limited studies evaluating early exposure and the progression of genetic variability of PA, our goal was to assess PA in young children with CF followed in two clinic types. Methods: A total of 39 infants with CF diagnosed through newborn screening were randomly assigned to either a segregated (PA-free) or mixed (PA-positive) clinic at two different CF centers, one of which replaced an older, mixed clinic where nosocomial acquisition was suspected. Oropharyngeal (OP) swab cultures were examined with subsequent genotyping to characterize the strains of PA isolated. Results: We found that 13/21 segregated clinic patients and 14/18 mixed clinic patients showed positive PA, with median acquisition ages of 3.3 and 2.2 years, respectively (P = 0.57). The median time to PA acquisition, however, was significantly longer in the new clinic with proper hygiene precautions compared to an old site (5.0 years vs. 1.7 years, P < 0.001). The majority of subjects isolated a single genotype of PA or AP-PCR types during the study period with eight subjects clearing the isolate after only one positive culture. The development of chronic colonization yielded the predominance of a single major genotype or AP-PCR type. Conclusions: Segregation of infants and young children with CF in PA-negative or PA-positive clinics did not alter the time to first PA isolation in this randomized assessment of facilities with hygienic precautions. During the early infection period where PA is first isolated in young children with CF, patients cleared different PA strains until a predominant strain established permanent colonization. Pediatr Pulmonol. 2010; 45:708-716. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:708 / 716
页数:9
相关论文
共 50 条
  • [1] Pseudomonas aeruginosa Serological Analysis in Young Children With Cystic Fibrosis Diagnosed Through Newborn Screening
    Hayes, D., Jr.
    Farrell, P. M.
    Li, Z.
    West, S. E.
    PEDIATRIC PULMONOLOGY, 2010, 45 (01) : 55 - 61
  • [2] Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening
    Maselli, JH
    Sontag, MK
    Norris, JM
    MacKenzie, T
    Wagener, JS
    Accurso, FJ
    PEDIATRIC PULMONOLOGY, 2003, 35 (04) : 257 - 262
  • [3] Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years
    Kidd, Timothy J.
    Ramsay, Kay A.
    Vidmar, Suzanna
    Carlin, John B.
    Bell, Scott C.
    Wainwright, Claire E.
    Grimwood, Keith
    Wainwright, Claire E.
    Grimwood, Keith
    Francis, Paul W.
    Dakin, Carolyn
    Cheney, Joyce
    George, Narelle
    Carlin, John B.
    Robertson, Colin F.
    Vidmar, Suzanna
    Moodie, Marj
    Carzino, Rosemary
    Carter, Robert
    Armstrong, David S.
    Cooper, Peter J.
    Mckay, Karen
    Martin, A. James
    Whitehead, Bruce
    Hunter, John
    By-Rnes, Catherine A.
    Tiddens, Harm A.
    Graniel, Karla
    Gerbrands, Krista
    Mott, Lauren
    JOURNAL OF CYSTIC FIBROSIS, 2015, 14 (03) : 361 - 369
  • [4] Pseudomonas aeruginosa and Children With Cystic Fibrosis COMMENT
    Sala, Marc A.
    Jain, Mane
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2529 - E2530
  • [5] Bronchoscopy in Cystic Fibrosis Infants Diagnosed by Newborn Screening
    Stafler, Patrick
    Davies, Jane C.
    Balfour-Lynn, Ian M.
    Rosenthal, Mark
    Bush, Andrew
    PEDIATRIC PULMONOLOGY, 2011, 46 (07) : 696 - 700
  • [6] Effects of a Pseudomonas aeruginosa eradication policy in a cystic fibrosis clinic
    Davidson, A. George F.
    Chilvers, Mark A.
    Lillquist, Yolanda P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (06) : 615 - 621
  • [7] Antibody Response to Pseudomonas aeruginosa in Children With Cystic Fibrosis
    Milagres, Lucimar G.
    Castro, Tatiana L. A.
    Garcia, Daniely
    Cruz, Aline C.
    Higa, Laurinda
    Folescu, Tania
    Marques, Elizabeth A.
    PEDIATRIC PULMONOLOGY, 2009, 44 (04) : 392 - 401
  • [8] Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis
    Stanojevic, Sanja
    Waters, Valerie
    Mathew, Joseph L.
    Taylor, Louise
    Ratjen, Felix
    JOURNAL OF CYSTIC FIBROSIS, 2014, 13 (02) : 172 - 178
  • [9] Segregation of children with CF diagnosed via newborn screening and acquisition of Pseudomonas aeruginosa
    McKay, Karen O.
    Cooper, Peter J.
    van Asperen, Peter P.
    JOURNAL OF CYSTIC FIBROSIS, 2009, 8 (06) : 400 - 404
  • [10] Cyanide in bronchoalveolar lavage is not diagnostic for Pseudomonas aeruginosa in children with cystic fibrosis
    Stutz, M. D.
    Gangell, C. L.
    Berry, L. J.
    Garratt, L. W.
    Sheil, B.
    Sly, P. D.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 553 - 558